Clinical Trials Logo

Chronic Idiopathic Constipation clinical trials

View clinical trials related to Chronic Idiopathic Constipation.

Filter by:

NCT ID: NCT01600001 Completed - Clinical trials for Chronic Idiopathic Constipation

A Exploratory Study of KWA-0711 in Patients With Chronic Idiopathic Constipation (CIC)

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of KWA-0711 in Chronic Idiopathic Constipation (CIC) patients.

NCT ID: NCT01469819 Completed - Clinical trials for Chronic Idiopathic Constipation

Lubiprostone Effect on Gastrointestinal (GI) Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation

Start date: June 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if lubiprostone may change the rate of movement of food and activities in the stomach and intestines in subjects whose gastrointestinal (GI) tract is slower due to constipation. To be able to measure the time difference in the duration of transit of the FDA approved SmartPill capsule in all segments of gastrointestinal (GI) tract before and after exposure to lubiprostone. The investigators anticipate to capture the possibility to reduce/eliminate the small intestinal bacterial overgrowth in chronically constipated patients after administration of study drug- lubiprostone.

NCT ID: NCT01460225 Completed - Clinical trials for Chronic Idiopathic Constipation

Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation

Start date: September 2007
Phase: Phase 4
Study type: Interventional

This prospective study is designed to evaluate how lubiprostone may affect gastric motor and sensory function.

NCT ID: NCT01429987 Completed - Clinical trials for Chronic Idiopathic Constipation

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Start date: October 2011
Phase: Phase 2/Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo controlled, 12 week repeat oral dose, dose ranging study to determine the efficacy and safety of 3 doses of plecanatide compared to placebo in patients with Chronic Idiopathic Constipation (CIC).

NCT ID: NCT01372423 Completed - Clinical trials for Chronic Idiopathic Constipation

Evaluation of Clinical Equivalence Between Two Lubiprostone Products

Start date: May 2011
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the clinical equivalence and safety of the Test formulation of lubiprostone 24 mcg capsules compared to the marketed formulation AMITIZA® (lubiprostone) 24 mcg capsules (Sucampo Pharmaceuticals, Inc.) in patients with confirmed chronic idiopathic constipation.

NCT ID: NCT01053962 Completed - Clinical trials for Chronic Idiopathic Constipation

SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation

CIC
Start date: March 2010
Phase: Phase 2
Study type: Interventional

This is a Phase 2a, randomized, double-blind, placebo-controlled, 14-day repeat oral, dose ranging study to determine the safety, pharmacokinetics (PK) and pharmacodynamics (PD) effects of SP-304 in patients with chronic idiopathic constipation.